Cargando…
Guidelines for multi-model comparisons of the impact of infectious disease interventions
BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple mod...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699075/ https://www.ncbi.nlm.nih.gov/pubmed/31422772 http://dx.doi.org/10.1186/s12916-019-1403-9 |
_version_ | 1783444657185751040 |
---|---|
author | den Boon, Saskia Jit, Mark Brisson, Marc Medley, Graham Beutels, Philippe White, Richard Flasche, Stefan Hollingsworth, T. Déirdre Garske, Tini Pitzer, Virginia E. Hoogendoorn, Martine Geffen, Oliver Clark, Andrew Kim, Jane Hutubessy, Raymond |
author_facet | den Boon, Saskia Jit, Mark Brisson, Marc Medley, Graham Beutels, Philippe White, Richard Flasche, Stefan Hollingsworth, T. Déirdre Garske, Tini Pitzer, Virginia E. Hoogendoorn, Martine Geffen, Oliver Clark, Andrew Kim, Jane Hutubessy, Raymond |
author_sort | den Boon, Saskia |
collection | PubMed |
description | BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple models of interventions against infectious diseases. The primary target audience for these guidelines are researchers carrying out model comparison studies and policy-makers using model comparison studies to inform policy decisions. METHODS: The consensus process used for the development of the guidelines included a systematic review of existing model comparison studies on effectiveness and cost-effectiveness of vaccination, a 2-day meeting and guideline development workshop during which mathematical modellers from different disease areas critically discussed and debated the guideline content and wording, and several rounds of comments on sequential versions of the guidelines by all authors. RESULTS: The guidelines provide principles for multi-model comparisons, with specific practice statements on what modellers should do for six domains. The guidelines provide explanation and elaboration of the principles and practice statements as well as some examples to illustrate these. The principles are (1) the policy and research question – the model comparison should address a relevant, clearly defined policy question; (2) model identification and selection – the identification and selection of models for inclusion in the model comparison should be transparent and minimise selection bias; (3) harmonisation – standardisation of input data and outputs should be determined by the research question and value of the effort needed for this step; (4) exploring variability – between- and within-model variability and uncertainty should be explored; (5) presenting and pooling results – results should be presented in an appropriate way to support decision-making; and (6) interpretation – results should be interpreted to inform the policy question. CONCLUSION: These guidelines should help researchers plan, conduct and report model comparisons of infectious diseases and related interventions in a systematic and structured manner for the purpose of supporting health policy decisions. Adherence to these guidelines will contribute to greater consistency and objectivity in the approach and methods used in multi-model comparisons, and as such improve the quality of modelled evidence for policy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1403-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6699075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66990752019-08-26 Guidelines for multi-model comparisons of the impact of infectious disease interventions den Boon, Saskia Jit, Mark Brisson, Marc Medley, Graham Beutels, Philippe White, Richard Flasche, Stefan Hollingsworth, T. Déirdre Garske, Tini Pitzer, Virginia E. Hoogendoorn, Martine Geffen, Oliver Clark, Andrew Kim, Jane Hutubessy, Raymond BMC Med Guideline BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple models of interventions against infectious diseases. The primary target audience for these guidelines are researchers carrying out model comparison studies and policy-makers using model comparison studies to inform policy decisions. METHODS: The consensus process used for the development of the guidelines included a systematic review of existing model comparison studies on effectiveness and cost-effectiveness of vaccination, a 2-day meeting and guideline development workshop during which mathematical modellers from different disease areas critically discussed and debated the guideline content and wording, and several rounds of comments on sequential versions of the guidelines by all authors. RESULTS: The guidelines provide principles for multi-model comparisons, with specific practice statements on what modellers should do for six domains. The guidelines provide explanation and elaboration of the principles and practice statements as well as some examples to illustrate these. The principles are (1) the policy and research question – the model comparison should address a relevant, clearly defined policy question; (2) model identification and selection – the identification and selection of models for inclusion in the model comparison should be transparent and minimise selection bias; (3) harmonisation – standardisation of input data and outputs should be determined by the research question and value of the effort needed for this step; (4) exploring variability – between- and within-model variability and uncertainty should be explored; (5) presenting and pooling results – results should be presented in an appropriate way to support decision-making; and (6) interpretation – results should be interpreted to inform the policy question. CONCLUSION: These guidelines should help researchers plan, conduct and report model comparisons of infectious diseases and related interventions in a systematic and structured manner for the purpose of supporting health policy decisions. Adherence to these guidelines will contribute to greater consistency and objectivity in the approach and methods used in multi-model comparisons, and as such improve the quality of modelled evidence for policy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1403-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-19 /pmc/articles/PMC6699075/ /pubmed/31422772 http://dx.doi.org/10.1186/s12916-019-1403-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Guideline den Boon, Saskia Jit, Mark Brisson, Marc Medley, Graham Beutels, Philippe White, Richard Flasche, Stefan Hollingsworth, T. Déirdre Garske, Tini Pitzer, Virginia E. Hoogendoorn, Martine Geffen, Oliver Clark, Andrew Kim, Jane Hutubessy, Raymond Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title | Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title_full | Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title_fullStr | Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title_full_unstemmed | Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title_short | Guidelines for multi-model comparisons of the impact of infectious disease interventions |
title_sort | guidelines for multi-model comparisons of the impact of infectious disease interventions |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699075/ https://www.ncbi.nlm.nih.gov/pubmed/31422772 http://dx.doi.org/10.1186/s12916-019-1403-9 |
work_keys_str_mv | AT denboonsaskia guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT jitmark guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT brissonmarc guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT medleygraham guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT beutelsphilippe guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT whiterichard guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT flaschestefan guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT hollingsworthtdeirdre guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT garsketini guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT pitzervirginiae guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT hoogendoornmartine guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT geffenoliver guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT clarkandrew guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT kimjane guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions AT hutubessyraymond guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions |